Expression of the erbb3 gene product in breast cancer

British Journal of Cancer

Volumn 66, Issue 6, 1992, Pages 1116-1121

  Smith, P ^b   Dublin, E ^b   Hughes, C M ^a   Prigent, S A ^a   Gullick, W J ^a   Hurst, H C ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT;

ARTICLE; BREAST CANCER; CANCER SURVIVAL; CELL LINE; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MULTIGENE FAMILY; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL;

BLOTTING, SOUTHERN; BREAST; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMAN; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR, ERBB-3; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0027076771     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1992.420     Document Type: Article

References (24)

1. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D M., SEID-MAN, J.G., SMITH, J.A. & STRUHL, K. (1991). Current Protocols in Molecular Biology. John Wiley: New York
2. BARTER, J., BARTKOVA, J., KYPRIANOU, N., LALANI, E. N., STAS-KOVA, Z., SHEARER, M., CHANG, S. & TAYLOR-PAPADI-MITROU, J. (1991). Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc. Natl. Acad. Sci. USA, 88, 3520-2524
3. CLEVELAND, D.W., LOPATA, M.A., MACDONALD, R.J., COWAN, N.J., RUTTER, W.J. & KRISCHNER, M.W. (1980). Number and evolutionary conservation of α-and β-tubulin and cytoplasmic α-and gamma-actin genes using specific cloned cDNA probes. Cell, 20, 95-105
4. COSTA, S., STAMM, H., ALMENDRAL, A., LUDWIG, H., WYSS, R., FABBRO, D., ERNST, A., TAKAHASHI, A. & EPPENBERGER, U.(1988). Predictive value of EGF receptor in breast cancer. Lancet, 2, 1258
5. COX, D.R. (1972). Regression models and life tables. J.R. Statistic Soc., 34, 187-202
6. GULLICK, W.J. (1990). The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer. Int. J. Cancer Supply 5, 55-61
7. GULLICK, W.J. (19906). Inhibitors of growth factor receptors. In Carney, D. & Sikora, K. (eds) Genes and Cancer, John Wiley: Chichester, pp. 263-276
8. GULLICK, W.J., DOWNWARD, J., FOULKES, J.G. & WATERFIELD, M.D. (1986). Antibodies to the ATP-binding site of the human epidermal growth factor receptor as specific inhibitors of EGF stimulated protein tyrosine kinase activity. Eur. J. Biochem., 158, 245-253
9. GULLICK, W.J., HUGHES, CM., MELLON, K., NEAL, D.E. & LEMOINE, N.R. (1991a). Immunohistochemical detection of epidermal growth factor receptor expression in paraffin-embedded human tissues. J. Pathol. 164, 285-289
10. GULLICK, W.J., LOVE, S.B., WRIGHT, C., BARNES, D.M., GUSTER-SON, B., HARRIS, A.L. & ALTMAN, D.G. (1991b). c-
11. HAYWARD, J.L., MEAKIN, J.W. & STEWARD, H.J. (1978). Assessment of response and recurrence in breast cancer. Semin. Oncol., 5, 445-449
12. KING, R.J.B., HAYWARD, J.L., MASTERS, J.R.W., MILLIS, R.R. & RUBENS, R.D. (1979). The measurement of receptors for oest-radiol and progesterone in human breast tumours. In King, R.J.B. (ed.) Steroid Receptor Assays in Breast Tumours: Methodological and Clinical Aspects., Alpha Omega: Cardiff, p. 57
13. KRAUS, M.H., ISSING, W., MIKI, T., POPESCU, N.C. & AARONSON, S.A. (1989). Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. USA, 86, 9193-9197
14. KUMAR, R., SHEPHARD, H.M. & MENDELSOHN, J. (1991). Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells. Mol. Cell. Biol., 11, 976-986
15. LEMOINE, N.R., LOBRESCO, M., LEUNG, H.Y., BARTON, CM., HUGHES, C.M., PRIGENT, S.A., GULLICK, W.J. & KLOPPEL, G.(1992). The ERBB3 proto-oncogene in human pancreatic cancer. J. Pathol, (in press)
16. MIDGLEY, C.A., FISHER, C.J., BARTER, J., VOJTESEK, B., LANE, D.P. & BARNES, D.M. (1992). Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J. Cell Sci., 101, 183-189
17. PERREN, T.J. (1991). c-erbB-2 oncogene as a prognostic marker in breast cancer. Br. J. Cancer, 63, 328-332
18. PETO, R., PIKE, M.C., ARMITAGE, P., BRESLOW, N.E., COX, D.R., HOWARD, S.V., MANTEL, N., MCPHERSON, K., PETO, J. & SMITH, P.G. (1977). Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br. J. Cancer, 35, 1-39
19. PLOWMAN, G.D., WHITNEY, G.S., NEUBAUER, M.G., GREEN, J.M., MACDONALD, V.L., TODARO, G.J. & SHOYAB, M. (1990). Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc. Natl. Acad. Sci. USA, 87, 4905-4909
20. PRIGENT, S.A., LEMOINE, N.R., HUGHES, C M., PLOWMAN, G.D., SELDEN, C. & GULLICK, W.J. (1992). Expression of the c-erbB-3 protein in normal human adult and fetal tissues. Oncogene, in press
21. SAINSBURY, J.R.C., FARNDON, J.R., NEEDHAM, G.K., MALCOLM, A.J. & HARRIS, A.L. (1987). Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet, 1, 1398-1402
22. SHEPARD, H.M., LEWIS, G.D., SARUP, J.C., FENDLY, B.M., MANE-VAL, D., MORDENTI, J., FIGARI, I., KOTTS, C.E., PALLADINO, M.A. Jr., ULLRICH, A. & SLAMON, D. (1991). Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic. J. Clin. Immunol., 11, 117-127
23. SLAMON, D.J., CLARKE, G.M., WONG, S.G., LEVIN, W.J., ULLRICH, A. & MCGUIRE, W.L. (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-3/neu oncogene. Science, 235, 177-182
24. VENTER, D.J., TUZI, N.L., KUMAR, S. & GULLICK, W.J. (1987). Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistochemical assessment correlates with gene amplification. Lancet, i, 69-72